Drug Trial Radar · NCT04580420
Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD
Last checked: Nov 20, 2026Latest source record: Dec 24, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
28
Planned (sponsor's estimate)
Start
Apr 15, 2021
Primary completion
Dec 30, 2031
Study completion Jan 30, 2032
Sponsor
- Lead sponsor
- Dicerna Pharmaceuticals, Inc., a Novo Nordisk companyIndustry
- Sponsor type
- Industry
- First posted
- Oct 8, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this study is to evaluate DCR-PHXC in participants with PH1 and severe renal impairment, with or without dialysis.
Conditions
- Primary Hyperoxaluria Type 1
- End Stage Renal Disease
Interventions
DCR-PHXCDrug
Monthly dosing throughout study period
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety: Incidence of EventsTime frame: 180 days
- Safety: Incidence of EventsTime frame: 180 days
Locations
18 sites in 10 countries. Site status is shown where the registry gives one.
Clinical Trial Site
San Francisco, California · Active not recruiting
Clinical Trial Site
Boston, Massachusetts · Active not recruiting
Clinical Trial Site
Rochester, Minnesota · Recruiting
Clinical Trial Site
New York, New York · Active not recruiting
Clinical Trial Site
Bron, France · Withdrawn
Clinical Trial Site
Paris, France · Withdrawn
Clinical Trial Site
Bonn, Germany · Recruiting
Clinical Trial Site
Heidelberg, Germany · Withdrawn
Clinical Trial Site
Roma, Italy · Withdrawn
Clinical Trial Site
Beirut, Lebanon · Recruiting
Clinical Trial Site
Casablanca, Morocco · Withdrawn
Clinical Trial Site
Oradea, Romania · Withdrawn
Clinical Trial Site
Oradea, Romania · Withdrawn
Clinical Trial Site
Barcelona, Spain · Recruiting
Clinical Trial Site
Santa Cruz de Tenerife, Spain · Withdrawn
Clinical Trial Site
Dubai, United Arab Emirates · Recruiting
Clinical Trial Site
London, United Kingdom · Withdrawn
Clinical Trial Site
London, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.